Paindrainer AB shortlisted for prominent Life Science Awards at NLSDays 2024

Report this content

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB, is proud to be selected as one of few companies shortlisted for the esteemed Nordic Star pitch competition. This prestigious pitch competition will take place at Nordic Life Science Days (NLSDays) in Malmö, Sweden on September 18-19, 2024.

NLSDays, the premier Nordic life science event, has curated a competitive shortlist of small- and medium-sized private companies excelling in research and development. Paindrainer AB’s inclusion in this list highlights its groundbreaking work in developing AI-powered innovative and evidence-based solutions aimed at improving the quality of life for individuals with chronic pain.

"Being shortlisted for the Nordic Star pitch competition is a tremendous honor and a testament to our unique digital solution for self-management of chronic pain and our team's dedication to innovative solutions in health technology. We look forward to showcasing our business opportunities at NLSDays and exploring further openings for commercial growth and collaboration.," says Erik Frick, CEO Paindrainer AB.

At the event, Paindrainer AB will present to an audience of investors, industry leaders, and conference delegates. The jury, composed of seasoned investors and pharmaceutical representatives, will evaluate the pitches to select the company with the highest investment potential.

For more information, please contact:

Erik Frick
CEO
Paindrainer AB
erik.frick@paindrainer.com
+46 736 61 21 23

Paindrainer AB is a company developing digital platforms and applications contributing to health and well-being. Paindrainer was founded in 2018 by Prof. Carl Borrebaeck, Dr. Maria Rosén Klement, and Göran Barkfors. The idea was born when Maria, after participating in several pain rehabilitation programs, realized that pain is affected by many more factors than the human brain can comprehend.

Paindrainer® is the first evidence-based AI powered digital tool demonstrating improved quality of life in individuals living with chronic pain. The digital tool coaches the users in managing their pain and provides guidance on how to reach a personalized activity balance to reach an optimal functional level and alleviate pain. The solution is powered by leveraging advanced algorithms and is fully adaptive to each user, a feature called 360o patient-centricity©.

Paindrainer® (Paindrainer PD1) is an FDA registered Medical Device Class 1 (510k exemption), MDR compliant and CE certified.

www.paindrainer.com

Subscribe